Top-line outcomes at the 48-week primary endpoint, by dose: Notable Phase 2 finding particularly relevant to the 10mg vial: the 1mg/week cohort still produced 8.7% mean weight loss over 48 weeks, clinically meaningful activity even at sub-therapeutic doses relative to the 12mg maximum
19 Clinical data thus far has been encouraging
We simply try to be thoughtful about the kind of risk were taking, and that one, we just cant find an asset that makes sense for us.
Two days after the first intramuscular B12 injection, the patient developed an acneiform eruption on her glabella, nose, cheeks, and perioral area
Through in vivo electrophysiological recordings, we found that the firing frequency of excitatory neurons in the medial prefrontal cortex of knockout mice is abnormal in both resting and task states, which may explain the autistic-like phenotypes exhibited by these mice
Healthcare providers do not recommend semaglutide for people with a history of pancreatitis or allergic reactions to semaglutide